{"id":"W2886065680","doi":"10.1016/j.euo.2018.07.003","title":"Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration","year":2018,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Carboplatin; Medicine; Gemcitabine; Oncology; Internal medicine; Cisplatin; Hazard ratio; Chemotherapy; Metastatic Urothelial Carcinoma; Cancer; Bladder cancer; Urothelial carcinoma; Nivolumab; Confidence interval; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001043936,0.0002509042,0.0007958271,0.0001417943,0.0001557017,0.000006860212,0.0001654532,0.00005166388,0.00003374037],"category_scores_gemma":[0.00007755818,0.0001732993,0.00009501706,0.0002079084,0.0003145232,0.00004410874,0.00002476554,0.0001825883,0.00001985849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001288637,"about_ca_system_score_gemma":0.0002626784,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002937377,"about_ca_topic_score_gemma":0.001386671,"domain_scores_codex":[0.9960538,0.002546658,0.000534103,0.000394809,0.0001484736,0.0003221485],"domain_scores_gemma":[0.9980965,0.001080442,0.0002661356,0.0002966911,0.000188766,0.00007152621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3339076,0.04992893,0.5061535,0.0003767874,0.002370606,0.0005348813,0.08035934,0.00004196787,0.001786251,0.00008260102,0.0005194623,0.02393811],"study_design_scores_gemma":[0.08384993,0.2321035,0.6809677,0.00001589508,0.0004421014,0.00002205532,0.0005970675,0.0001658497,0.0005583275,0.00001336223,0.001149697,0.0001144794],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930397,0.0001055499,0.0003965315,0.0003669195,0.0003936812,0.004084267,0.000145187,0.00001900896,0.001449211],"genre_scores_gemma":[0.9987604,0.0000077635,0.0001301791,0.000470445,0.0001591155,0.0002482703,0.0001793131,0.00003144928,0.00001308653],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2500577,"threshold_uncertainty_score":0.706694,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07254437410222264,"score_gpt":0.412456320571144,"score_spread":0.3399119464689213,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}